| 摘要 |
The invention relates to methods and compositions for treating schizophrenia or bipolar disorder (in particular, mania) by using a combination of a α5 -containing GABAA receptor agonist and an antipsychotic or their pharmaceutically acceptable salts, hydrates, solvates, polymorphs thereof. In some enbodiments, the methods and the compositions are for treating one or more positive and/or negative symptoms, as well as cognitive impairment, associated with schizophrenia. |
